Could Intravenous Immunoglobulin (IVIG) Help in Long Covid and ME/CFS?
A clinical overview for families and physicians — by Buonsenso and the Kids
Intravenous immunoglobulin (IVIG) is not a new therapy — it’s been used for decades to treat autoimmune and inflammatory conditions, including neurological syndromes. But in recent years, its use is being explored in post-viral syndromes like Long Covid and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) — particularly when these conditions present in children and adolescents with signs of immune dysfunction.
In this post, we’ll explore:
Why IVIG might help
The current evidence
Pros and cons of treatment
Monitoring response and side effects
What a reasonable protocol might look like

